Xueting Liu
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
TAX1BP1/A20 inhibited TLR2-NF-κB activation to induce tolerant expression of IL-6 in endothelial cells.
Journal: International immunopharmacology
Published: March 21, 2024
STAT3 promotes cytoplasmic-nuclear translocation of RNA-binding protein HuR to inhibit IL-1β-induced IL-8 production.
Journal: International immunopharmacology
Published: November 25, 2023
Proteasome activation is critical for cell death induced by inhibitors of polo-like kinase 1 (PLK1) in multiple cancers.
Journal: European journal of pharmacology
Published: November 14, 2023
A Novel Biological Activity of the STAT3 Inhibitor Stattic in Inhibiting Glutathione Reductase and Suppressing the Tumorigenicity of Human Cervical Cancer Cells via a ROS-Dependent Pathway.
Journal: OncoTargets and therapy
Published: April 07, 2021
Proteasome inhibitors decrease paclitaxel‑induced cell death in nasopharyngeal carcinoma with the accumulation of CDK1/cyclin B1.
Journal: International journal of molecular medicine
Published: March 25, 2021
miR-543 in human mesenchymal stem cell-derived exosomes promotes cardiac microvascular endothelial cell angiogenesis after myocardial infarction through COL4A1.
Journal: IUBMB life
Published: December 14, 2020
Pharmacological inhibition of GSK3 promotes TNFα-induced GM-CSF via up-regulation of ERK signaling in nasopharyngeal carcinoma (NPC).
Journal: International immunopharmacology
Published: December 02, 2019
IL-1α and IL-1β promote NOD2-induced immune responses by enhancing MAPK signaling.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: September 07, 2018
The activation of Toll-like receptor 4 reverses tumor differentiation in human glioma U251 cells via Notch pathway.
Journal: International immunopharmacology
Published: March 16, 2018
TNFα induces tolerant production of CXC chemokines in colorectal cancer HCT116 cells via A20 inhibition of ERK signaling.
Journal: International immunopharmacology
Published: October 20, 2017
Last Updated: 09/26/2026